[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 9, 2006

Aromatase Inhibitors and Breast Cancer Treatment

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;296(6):651. doi:10.1001/jama.296.6.651-a

To the Editor: In his Clinical Crossroads article, Dr Come1 outlines adjuvant therapy options for postmenopausal breast cancer patients and raises safety concerns for aromatase inhibitors regarding fractures and lipid profile change. However, no protocol-defined screening or therapy related to bone health was used in any aromatase inhibitor trial, and guidelines are now available to inform management of this issue.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×